Phase II Trial for Stage III and IVa Head and Neck Cancer
![image2](https://www.med.unc.edu/radonc/wp-content/uploads/sites/815/2018/07/tepper-publishes-imrt-cisplatin-study-in-ijrob-image2.jpeg)
Joel Tepper, M.D. and colleagues have published an article entitled Phase II Trial of Hyperfractionated Intensity-Modulated Radiation Therapy and Concurrent Weekly Cisplatin for Stage III and IVa Head-and-Neck Cancer published in the March 15, 2011 issue of the International Journal of Radiation Oncology•Biology•Physics (Volume 79, Number 4).